Influenza Virus-Like Particles as Pandemic Vaccines
Sang‐Moo Kang(Georgia State University), Richard W. Compans(Emory University), Gale Smith(Novavax (United States)), Rick A. Bright(Waterford Institute), Peter Pushko(Novavax (United States))
Cited by 74
Related Papers
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
|The Lancet|2005|734
Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
|Nature Immunology|2010|690
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
|JAMA|2006|672
Transmission of Equine Influenza Virus to Dogs
|Science|2005|652
Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide
|The Journal of Infectious Diseases|2007|547